Global /China /Basic Materials /Specialty Chemicals /301258

Suzhou Fushilai Pharmaceutical Co., Ltd.

301258

• SHE: 301258 • Delayed

29.88CNY 2.8%

4.42 USD

As of 18 June 2026, Suzhou Fushilai Pharmaceutical Co., Ltd. has a market cap of $396.5M USD, ranking #16765 globally and #5241 in China. It ranks #1783 in the Basic Materials sector, and #594 in the Specialty Chemicals industry.

Global Rank

16765

Country Rank

5241

Sector Rank

1783

Industry Rank

594

Key Stats

Market Cap

$396.5MUSD

2.68B CNY

Enterprise Value

$224.35MUSD

1.52B CNY

Revenue (TTM)

$61.04MUSD

412.51M CNY

EBITDA (TTM)

$5.13MUSD

34.66M CNY

Net Income (TTM)

$5.56MUSD

37.59M CNY

EBITDA Margin

8.4%

Profit Margin

9.1%

PE Ratio

71.6

PS Ratio

6.5

PB Ratio

1.4

EV/EBITDA

43.0

Company Profile

Country (HQ)

China

Sector

Basic Materials

Industry

Specialty Chemicals

CEO

Xiangyun Qian open_in_new

Employees

524

Founded

2000

Website

fuslai.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
2.8%	-7.1%	-6%	-14%	-15%	-8.1%	6.7%	-28%	-61%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	301258 苏州富士莱医药股份有限公司 Class A ISIN: CNE1000058W2 Shares Out.: Shares Outstanding: 85.985M¹ TV: TradingView: SZSE: 301258 SA: Stock Analysis: SHE: 301258 YF: Yahoo Finance: 301258.SZ GF: Google Finance: SHE: 301258 BA: Barron's: 301258 MS: Morningstar: XSHE: 301258	29.88 CNY	TV: TradingView: SZSE: 301258 SA: Stock Analysis: SHE: 301258 YF: Yahoo Finance: 301258.SZ GF: Google Finance: SHE: 301258 BA: Barron's: 301258 MS: Morningstar: XSHE: 301258

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Suzhou Fushilai Pharmaceutical Co., Ltd.

Suzhou Fushilai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and health care raw materials in China and internationally. The company offers lipoic acid products comprising granular alpha lipoic acid, R-lipoic acid, r-lipoic acid tromethamine salt, and 6,8-dichlorooctanoic acid ethyl ester; l-carnosine; phosphatidylcholine products, which include glycerylphosphatidylcholine; and erelcoxib API, a nonsteroidal anti-inflammatory analgesic used to relieve the pain symptoms of osteoarthritis. Its products are used in medicines, dietary supplements, and cosmetics applications. The company also engages in research and experimental development and capital market activities. The company exports its products to Europe, America, and Southeast Asia. Suzhou Fushilai Pharmaceutical Co., Ltd. was founded in 2000 and is based in Changshu, China.

Similar Companies

Industry: Specialty Chemicals (China)

Name	Market Cap (USD) diff.	PE	Country
Wanhua Chemical Group Co., Ltd. SSE: 600309	$41.48B 280.3B CNY 10K%	21.3	China
Ningxia Baofeng Energy Group Co., Ltd. SSE: 600989	$33.5B 226.4B CNY 8K%	18.0	China
China Northern Rare Earth (Group) High-Tech Co.,Ltd SSE: 600111	$27.25B 184.19B CNY 7K%	67.3	China
Ganfeng Lithium Group Co., Ltd. SHE: 002460	$25.8B 174.39B CNY 6K%	47.3	China
Hengli Petrochemical Co.,Ltd. SSE: 600346	$23.14B 156.41B CNY 6K%	17.4	China
China Jushi Co., Ltd. SSE: 600176	$20.96B 141.68B CNY 5K%	37.3	China

Industry: Specialty Chemicals (Global)

Name	Market Cap (USD) diff.	PE	Country
Linde plc NASDAQ: LIN	$233.88B 59K%	34.5	United Kingdom
Air Liquide S.A. EPA: AI	$120.92B 104.79B EUR 30K%	29.9	France
Shin-Etsu Chemical Co., Ltd. TSE: 4063	$81.92B 13.15T JPY 21K%	28.0	Japan
The Sherwin-Williams Co. NYSE: SHW	$77.94B 20K%	30.5	United States
Ecolab Inc. NYSE: ECL	$72.47B 18K%	34.7	United States
Air Products and Chemicals, Inc. NYSE: APD	$67.35B 17K%	-	United States

chevron_leftBack